These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of synthetic protease inhibitors on superoxide (O2-), hydrogen peroxide (H2O2) and hydroxyl radical production by human polymorphonuclear leukocytes. Tamura K, Manabe T, Imanishi K, Nonaka A, Asano N, Yamaki K, Tobe T. Hepatogastroenterology; 1992 Feb; 39(1):59-61. PubMed ID: 1314767 [Abstract] [Full Text] [Related]
5. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M, Aoyama T. Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760 [Abstract] [Full Text] [Related]
7. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)]. Koshiyama Y, Kobori A, Ogihara M, Yokomoto Y, Ohtani K, Shimamura K, Iwaki M. Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413 [Abstract] [Full Text] [Related]
8. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro]. Ino Y, Suzuki K, Sato T, Iwaki M. Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641 [Abstract] [Full Text] [Related]
9. Protease inhibitor nafamostat mesilate attenuates complement activation and improves function of xenografts in a discordant lung perfusion model. Tagawa T. Xenotransplantation; 2011 Dec; 18(6):315-9. PubMed ID: 22168138 [Abstract] [Full Text] [Related]
10. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. Kitagawa S, Takaku F, Sakamoto S. J Clin Invest; 1980 Jan; 65(1):74-81. PubMed ID: 6243143 [Abstract] [Full Text] [Related]
11. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S, Fujita M. Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087 [Abstract] [Full Text] [Related]
12. Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes. Minta JO, Williams MD. J Rheumatol; 1986 Jun; 13(3):498-504. PubMed ID: 3016258 [Abstract] [Full Text] [Related]
16. Response of superoxide anion production by guinea pig eosinophils to various soluble stimuli: comparison to neutrophils. Yamashita T, Someya A, Hara E. Arch Biochem Biophys; 1985 Sep; 241(2):447-52. PubMed ID: 2994568 [Abstract] [Full Text] [Related]
17. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation]. Tsukagoshi S. Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450 [Abstract] [Full Text] [Related]
18. Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation. Ino Y, Sato T, Koshiyama Y, Suzuki K, Oda M, Iwaki M. Gen Pharmacol; 1987 May; 18(5):513-6. PubMed ID: 3308629 [Abstract] [Full Text] [Related]
20. [Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro]. Nakamura K, Johmura A, Oda M, Ino Y, Uchiyama H, Ohtani H, Miyazaki H, Kurumi M, Akizawa Y, Oka T. Yakugaku Zasshi; 1995 Mar; 115(3):201-12. PubMed ID: 7738778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]